Filtering by:
Skin CancerFDA Approves Libtayo (Cemiplimab) for a Type of Skin Cancer
The US Food and Drug Administration (FDA) has approved Libtayo (cemiplimab) to treat people with advanced squamous cell carcinoma of the skin.
How to Spot Skin Cancer
Skin cancer is by far the most common type of cancer. If you know what to look for, you can spot warning signs of skin cancer early.
Melanoma and Thyroid Cancer Survivor Has Inherited Syndrome
Cowden disease is a type of PTEN hamartoma tumor syndrome (PHTS) caused by a mutation in the PTEN gene. PHTS raises the risk of developing certain types of cancer, including skin, thyroid, breast, endometrial, colorectal, and kidney.
Microorganisms Living on Your Skin May Relate to Skin Cancer Risk
The viruses, fungi, and bacteria on your skin could provide clues for skin cancer development and treatment.
FDA Approves Keytruda (Pembrolizumab) for Any Tumor with Specific Genetic Change
The US Food and Drug Administration (FDA) has expanded the approval of the immunotherapy drug Keytruda (pembrolizumab) to include tumors with a specific genetic change regardless of cancer type.
Melanoma Survivor Finds Hope Through Immunotherapy
When Bryant Wieneke started feeling “funky” in April 2016, he figured it was just part of getting older. A urine test revealed abnormal cells, which led to more testing and eventually, a diagnosis of advanced melanoma skin cancer.
Dispelling Myths to Decrease Skin Cancer in Latinos
Having darker skin doesn’t prevent skin cancer. A new study is looking at myths about sun protection and Latinos in order to develop resources to help.
FDA Approves First Drug for Merkel Cell Carcinoma
The US Food and Drug Administration (FDA) has approved Bavencio (avelumab) for Merkel cell carcinoma that has spread to other parts of the body – the first time it’s approved a drug for this rare and aggressive type of skin cancer.